PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 130 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2016. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $257,309,000 | -20.1% | 36,706 | +4.7% | 0.00% | -33.3% |
| Q2 2021 | $321,841,000 | -0.9% | 35,059 | +4.9% | 0.00% | -25.0% |
| Q1 2021 | $324,891,000 | -2.0% | 33,425 | +3.4% | 0.00% | +33.3% |
| Q4 2020 | $331,562,000 | +41.1% | 32,316 | +38.7% | 0.00% | 0.0% |
| Q3 2020 | $235,066,000 | +19488.8% | 23,297 | -75.3% | 0.00% | -72.7% |
| Q2 2019 | $1,200,000 | +102.7% | 94,439 | +844.1% | 0.01% | +266.7% |
| Q2 2018 | $592,000 | -64.9% | 10,003 | -59.7% | 0.00% | -70.0% |
| Q1 2018 | $1,687,000 | -48.3% | 24,794 | -71.7% | 0.01% | -63.0% |
| Q1 2017 | $3,264,000 | +466.7% | 87,755 | +921.6% | 0.03% | +440.0% |
| Q3 2016 | $576,000 | +1.4% | 8,590 | +186.4% | 0.01% | -28.6% |
| Q4 2014 | $568,000 | -66.8% | 2,999 | -88.4% | 0.01% | -61.1% |
| Q2 2014 | $1,712,000 | – | 25,936 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $5,108,000 | 2.15% |
| Camber Capital Management LP | 4,235,000 | $12,070,000 | 0.52% |
| Kynam Capital Management, LP | 579,915 | $1,653,000 | 0.42% |
| GLOBEFLEX CAPITAL L P | 419,322 | $1,195,000 | 0.29% |
| Eversept Partners, LP | 1,435,077 | $4,089,969 | 0.29% |
| ARMISTICE CAPITAL, LLC | 1,500,000 | $4,275,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 506,066 | $1,442,000 | 0.07% |
| XTX Topco Ltd | 36,130 | $103,000 | 0.04% |
| State of Wyoming | 20,732 | $59,000 | 0.04% |
| Patriot Financial Group Insurance Agency, LLC | 55,500 | $158,000 | 0.03% |